Metactive Medical fetches $1.2 mln Series A

Metactive Medical Inc, a developer of products for the treatment of neurovascular, peripheral vascular and structural heart diseases, has raised $1.2 million in Series A financing. The investors included Mid-America Angels and Serra Ventures.

8 March 2018•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail